Treatment for Acute Wounds

Phase-Based Progress Estimates
Brooke Army Medical Center, Fort Sam Houston, TX
Acute Wounds+1 More
Antimicrobial Skin & Wound Cleanser - Device
All Sexes
What conditions do you have?

Study Summary

The proposed study will be a prospective trial of management of acute traumatic wounds (less than 24 hours from injury and without previous intervention aside from a dressing for coverage). The study design involves a prospective single arm, 35 subject study that analyzes the effect of the subsequent application of a novel wound cleanser and wound gel on subjects' acute traumatic wounds and the respective microbial loads over a 28 day study duration.

Eligible Conditions

  • Acute Wounds

Treatment Effectiveness

Study Objectives

1 Primary · 1 Secondary · Reporting Duration: 28 days

28 days
Microbial Load
Wound Healing Rates

Trial Safety

Trial Design

1 Treatment Group

1 of 1
Experimental Treatment

35 Total Participants · 1 Treatment Group

Primary Treatment: Treatment · No Placebo Group · N/A

TreatmentExperimental Group · 4 Interventions: Antimicrobial Skin & Wound Cleanser, Antimicrobial Wound Gel, Antimicrobial Wound Gel (AWG), Antimicrobial Skin & Wound Cleanser (AWC) · Intervention Types: Device, Device, Device, Device

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 28 days
Closest Location: Brooke Army Medical Center · Fort Sam Houston, TX
2011First Recorded Clinical Trial
1 TrialsResearching Acute Wounds
258 CompletedClinical Trials

Eligibility Criteria

Age 18+ · All Participants · 6 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
Patients being treated at Brooke Army Medical Center (BAMC) or those identified in the Department of Defense Trauma Registry (DoDTR) with acute traumatic wounds (beneficiary and civilian trauma patients as all have eligibility for follow up post discharge).
You have a wound area > 4 cm2.
You have a wound which includes partial and full thickness skin tears.
You are able to read and/ or speak English.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.